Hsien-Yuan Lane
China Medical University, Taiwan
Biography
<div id="cke_pastebin" style="position: absolute; left: -1000px; top: 16px; width: 1px; height: 1px; overflow: hidden;">
Hsien-Yuan Lane, M.D.,Ph.D. is the Director and Professor of Department of Psychiatry and Institute of Clinical Medical Science at China Medical University Medical College, Taichung, Taiwan. He has been devoted to translational studies and clinical trials, especially those on several NMDA-enhancing agents for treatment of various mental disorders. His team is the first group to demonstrate the therapeutic efficacy of glycine transporter I inhibitor in patients with schizophrenia, setting the tone of these lines of novel treatments. </div>
<div id="cke_pastebin" style="position: absolute; left: -1000px; top: 16px; width: 1px; height: 1px; overflow: hidden;">
<div>
Hsien-Yuan Lane, M.D.,Ph.D. is the Director and Professor of Department of Psychiatry and Institute of Clinical Medical Science at China Medical University Medical College, Taichung, Taiwan. He has been devoted to translational studies and clinical trials, especially those on several NMDA-enhancing agents for treatment of various mental disorders. His team is the first group to demonstrate the therapeutic efficacy of glycine transporter I inhibitor in patients with schizophrenia, setting the tone of these lines of novel treatments. </div>
<div>
</div>
</div>
<div id="cke_pastebin" style="position: absolute; left: -1000px; top: 16px; width: 1px; height: 1px; overflow: hidden;">
Hsien-Yuan Lane, M.D.,Ph.D. is the Director and Professor of Department of Psychiatry and Institute of Clinical Medical Science at China Medical University Medical College, Taichung, Taiwan. He has been devoted to translational studies and clinical trials, especially those on several NMDA-enhancing agents for treatment of various mental disorders. His team is the first group to demonstrate the therapeutic efficacy of glycine transporter I inhibitor in patients with schizophrenia, setting the tone of these lines of novel treatments. </div>
<div id="cke_pastebin" style="position: absolute; left: -1000px; top: 16px; width: 1px; height: 1px; overflow: hidden;">
<div>
Hsien-Yuan Lane, M.D.,Ph.D. is the Director and Professor of Department of Psychiatry and Institute of Clinical Medical Science at China Medical University Medical College, Taichung, Taiwan. He has been devoted to translational studies and clinical trials, especially those on several NMDA-enhancing agents for treatment of various mental disorders. His team is the first group to demonstrate the therapeutic efficacy of glycine transporter I inhibitor in patients with schizophrenia, setting the tone of these lines of novel treatments. </div>
<div>
<div>
Hsien-Yuan Lane, M.D.,Ph.D. is the Director and Professor of Department of Psychiatry and Institute of Clinical Medical Science at China Medical University Medical College, Taichung, Taiwan. He has been devoted to translational studies and clinical trials, especially those on several NMDA-enhancing agents for treatment of various mental disorders. His team is the first group to demonstrate the therapeutic efficacy of glycine transporter I inhibitor in patients with schizophrenia, setting the tone of these lines of novel treatments. </div>
<p>
</p>
</div>
</div>